Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Lockhart SP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yonekawa M; Ohigesenseino Kodomo Clinic, Sapporo, Hokkaido, Japan. Electronic address: ohige_kodomoclinic@me.com., Watanabe T; Watanabe Pediatric Allergy Clinic, Sapporo, Hokkaido, Japan., Kogawara O; Vaccine Research, Pfizer R&D Japan, Tokyo, Japan., Yoshii C; Vaccine Research, Pfizer R&D Japan, Tokyo, Japan., Yamaji M; Vaccine Research, Pfizer R&D Japan, Tokyo, Japan., Aizawa M; Vaccine Research, Pfizer R&D Japan, Tokyo, Japan., Erber W; Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines, Vienna, Austria., Ito S; Vaccine Medical Affairs, Pfizer Japan Inc, Tokyo, Japan., Jug B; QC Logistics, Pfizer Manufacturing Austria GmbH, Orth an der Donau, Austria., Koelch D; Vaccines Analytical Development, Pfizer, Orth, Austria., de Solom R; Pfizer Australia, Sydney, NSW, Australia., Lockhart SP; Vaccine Research and Development, Pfizer Ltd, Hurley, UK.
Publikováno v:
Vaccine [Vaccine] 2024 May 10; Vol. 42 (13), pp. 3180-3189. Date of Electronic Publication: 2024 Apr 12.
Autor:
Remich S; Pfizer Vaccine Research and Development, Collegeville, Pennsylvania., Kitchin N; Pfizer Vaccine Research and Development, Hurley, United Kingdom., Peterson J; Foothill Family Clinic, Salt Lake City, Utah., Li P; Pfizer Vaccine Research and Development, Collegeville, Pennsylvania., Pride MW; Pfizer Vaccine Research and Development, Pearl River, New York., Brock L; Pfizer Vaccine Research and Development, Pearl River, New York., Anderson AS; Pfizer Vaccine Research and Development, Pearl River, New York., Gruber WC; Pfizer Vaccine Research and Development, Pearl River, New York., Jansen KU; Pfizer Vaccine Research and Development, Pearl River, New York., Lockhart SP; Pfizer Vaccine Research and Development, Hurley, United Kingdom., Webber C; Pfizer Vaccine Research and Development, Hurley, United Kingdom.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Feb 14; Vol. 229 (2), pp. 367-375.
Autor:
Christensen S; J. Lewis Research, Salt Lake City, UT, USA., Bouguermouh S; Pfizer Inc, Pearl River, NY, USA. Electronic address: salim.bouguermouh@pfizer.com., Ilangovan K; Pfizer Inc, Collegeville, PA, USA., Pride MW; Pfizer Inc, Pearl River, NY, USA., Webber C; Pfizer Ltd, Hurley, UK., Lockhart SP; Pfizer Ltd, Hurley, UK., Shah R; Pfizer Inc, Pearl River, NY, USA., Kitchin N; Pfizer Ltd, Hurley, UK., Lamberth E; Pfizer Inc, Collegeville, PA, USA., Zhang H; Pfizer Inc, Collegeville, PA, USA., Gao Q; Pfizer Inc, Collegeville, PA, USA., Brock L; Pfizer Inc, Pearl River, NY, USA., Anderson AS; Pfizer Inc, Pearl River, NY, USA., Gruber WC; Pfizer Inc, Pearl River, NY, USA.
Publikováno v:
Vaccine [Vaccine] 2023 Dec 07; Vol. 41 (50), pp. 7548-7559. Date of Electronic Publication: 2023 Nov 17.
Autor:
Murdoch L; Emeritus Research, Camberwell, VIC, Australia., Quan K; Vaccine Clinical Research and Development, Pfizer Australia Pty Ltd, Sydney, NSW, Australia. Karen.Quan@pfizer.com., Baber JA; Vaccine Clinical Research and Development, Pfizer Australia Pty Ltd, Sydney, NSW, Australia., Ho AWY; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., Zhang Y; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., Xu X; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA., Lu C; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Cooper D; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Koury K; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Lockhart SP; Vaccine Research and Development, Pfizer Ltd, Hurley, UK., Anderson AS; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Türeci Ö; BioNTech, Mainz, Germany., Şahin U; BioNTech, Mainz, Germany., Swanson KA; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Gruber WC; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA., Kitchin N; Vaccine Research and Development, Pfizer Ltd, Hurley, UK.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2023 Sep; Vol. 12 (9), pp. 2241-2258. Date of Electronic Publication: 2023 Sep 12.
Autor:
Thomas SJ; State University of New York, Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. Electronic address: ThomStep@upstate.edu., Perez JL; Pfizer Inc., 500 Arcola Rd., Collegeville, PA 19426, USA. Electronic address: John.Perez@pfizer.com., Lockhart SP; Pfizer Inc., Horizon Honey Lane, Maidenhead SL6 6RJ, UK. Electronic address: Stephen.P.Lockhart@pfizer.com., Hariharan S; Pfizer Inc., 235 East 42nd Street, New York, NY 10017, USA. Electronic address: s.hariharan@pfizer.com., Kitchin N; Pfizer Inc., Horizon Honey Lane, Maidenhead SL6 6RJ, UK. Electronic address: Nicholas.Kitchin@pfizer.com., Bailey R; Pfizer Inc., Horizon Honey Lane, Maidenhead SL6 6RJ, UK. Electronic address: Ruth.Bailey@pfizer.com., Liau K; Pfizer Inc., 10555 Science Center Drive, San Diego, CA 92121, USA. Electronic address: Katherine.F.Liau@pfizer.com., Lagkadinou E; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany. Electronic address: Eleni.Lagkadinou@biontech.de., Türeci Ö; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany. Electronic address: Oezlem.Tuereci@biontech.de., Şahin U; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany. Electronic address: sahin@uni-mainz.de., Xu X; Pfizer Inc., 500 Arcola Rd., Collegeville, PA 19426, USA. Electronic address: Xia.Xu3@pfizer.com., Koury K; Pfizer Inc., 401 N. Middletown Rd, Pearl River, NY 10965, USA. Electronic address: Kenneth.Koury@pfizer.com., Dychter SS; Pfizer Inc., 10555 Science Center Drive, San Diego, CA 92121, USA. Electronic address: Samuel.Dychter@pfizer.com., Lu C; Pfizer Inc., 401 N. Middletown Rd, Pearl River, NY 10965, USA. Electronic address: Claire.Lu@pfizer.com., Gentile TC; State University of New York, Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. Electronic address: GentileT@upstate.edu., Gruber WC; Pfizer Inc., 401 N. Middletown Rd, Pearl River, NY 10965, USA. Electronic address: Bill.Gruber@pfizer.com.
Publikováno v:
Vaccine [Vaccine] 2022 Mar 01; Vol. 40 (10), pp. 1483-1492. Date of Electronic Publication: 2021 Dec 24.
Autor:
Lalwani SK; Department of Pediatrics, Bharati Vidyapeeth Medical College and Hospital, Pune, Maharashtra, India., Ramanan PV; Department of Pediatrics, Sri Ramachandra Hospital, Chennai, Tamil Nadu, India., Sapru A; Department of Pediatrics, KEM Hospital Research Centre, Pune, Maharashtra, India., Sundaram B; Department of Pediatrics, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, Tamil Nadu, India., Shah BH; Department of Pediatrics, B.J. Medical College and Civil Hospital, Ahmedabad, Gujarat, India., Kaul D; Department of Pediatrics, Sir Ganga Ram Hospital, New Delhi, India., Karthik Nagesh N; Department of Pediatrics, Manipal Hospital, Bengaluru, Karnataka, India., Kalina WV; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA., Chand R; Global Site and Study Operations, Pfizer Ltd, Mumbai, India., Ding M; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, USA., Suroju S; Vaccine Clinical Research and Development, Pfizer Ltd, Hurley, UK., Scott DA; Vaccine Clinical Research and Development, Pfizer Inc, Collegeville, PA, USA., Lockhart SP; Vaccine Clinical Research and Development, Pfizer Ltd, Hurley, UK. Electronic address: stephen.p.lockhart@pfizer.com.
Publikováno v:
Vaccine [Vaccine] 2021 Nov 05; Vol. 39 (46), pp. 6787-6795. Date of Electronic Publication: 2021 Oct 14.